From Clinical Thyroidology® for the Public: Radioactive iodine works as a “magic bullet” as it is taken up and stored only by thyroid cells, both normal and cancerous, and destroys them. While in the past most patients were treated with radioactive iodine therapy, the more recent practice is to be selective when considering who would benefit from this treatment. The IoN trial was designed to assess whether observation provided similar outcomes compared to administering radioactive iodine therapy in patients with thyroid cancer with a low-to-intermediate risk of recurrence. Read More…
We welcome your feedback and suggestions. Let us know what you want to see in this publication.
Feedback & Suggestions
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.